Literature DB >> 1957135

Prevalence of antibodies to HTLV-1 in South American Indians (Mapuches) from Chile.

J Inostroza1, P Diaz, C Saunier.   

Abstract

The seroprevalence of HTLV-1 antibodies was investigated in 405 serum samples from healthy South American Indians (Mapuches) from Chile, using enzyme linked immunoassay (ELISA), Western immunoblot (WB) and radioimmuno precipitation assay (RIPA). Six samples were positive by ELISA; 3 of them were confirmed by WB/RIPA. Thus, we observed a seroprevalence of 0.7% for HTLV-1 antibodies in healthy Mapuches.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1957135     DOI： 10.3109/00365549109075102

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN： 0036-5548


  4 in total

1.  Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes.

Authors:  S P Parker; M B Taylor; A E Ades; W D Cubitt; C Peckham
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

2.  Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.

Authors:  Luis Chandía; Cristina Sotomayor; Sylvia Ordenes; Pilar Salas; Maritza Navarrete; Mauricio Lopez; Carola Otth
Journal:  Med Microbiol Immunol       Date:  2010-08-13       Impact factor: 3.402

3.  Khorasan Disease: Prevalence of HTLV-I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) In West Azarbaijan from 2004 to 2007.

Authors:  R Boostani; A Mellat Ardakani; H Ashrafi
Journal:  Iran Red Crescent Med J       Date:  2011-06-01       Impact factor: 0.611

Review 4.  Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas.

Authors:  Arthur Paiva; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.